Is Cytek Biosciences Inc (CTKB) Stock a Good Value?

Cytek Biosciences Inc (CTKB) stock is lower by -73.37% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives CTKB stock a score of 31 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 0. CTKB's rank also includes a long-term technical score of 3.

CTKB has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on CTKB!

See Full CTKB Report

What's Happening with CTKB Stock Today

Cytek Biosciences Inc (CTKB) stock is down -1.9% while the S&P 500 is higher by 0.28% as of 1:26 PM on Wednesday, Nov 1. CTKB is lower by -$0.08 from the previous closing price of $4.21 on volume of 572,908 shares. Over the past year the S&P 500 has risen 9.06% while CTKB is lower by -73.37%. CTKB lost -$0.05 per share in the over the last 12 months. Click Here to get the full Stock Report for Cytek Biosciences Inc stock.